Skip to main content

Table 1 Genetic association models and disease risk

From: Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival

Model

Genotypes

Controls

Patients

Adjusted OR (95% CI)

P-value

Codominant

G/G

56 (53.9%)

51 (46.4%)

1.00

0.044

 

A/G

42 (40.4%)

41 (37.3%)

1.07 (0.60–1.90)

 
 

A/A

6 (5.8%)

18 (16.4%)

3.27 (1.20–8.88)

 

Dominant

G/G

56 (53.9%)

51 (46.4%)

1.00

0.28

 

A/G–A/A

48 (46.1%)

59 (53.6%)

1.35 (0.79–2.30)

 

Recessive

G/G–A/G

98 (94.2%)

92 (83.6%)

1.00

0.013

 

A/A

6 (5.8%)

18 (16.4%)

3.17 (1.20–8.34)

 

Over-dominant

G/G–A/A

62 (59.6%)

69 (62.7%)

1.00

0.64

 

A/G

42 (40.4%)

41 (37.3%)

0.88 (0.51–1.52)

 

Log-additive

–

–

–

1.48 (0.99–2.22)

0.053

  1. Data are presented as number (percentage). Adjusted odds ratio (OR) by age. Bold values indicate statistical significance at P-value < 0.05
  2. CI confidence interval